Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity. Ceribelli M, Tosto FA, Zhang X, Melani CJ, et al. Proc Natl Acad Sci U S A 2024;121:e2413372121.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ceribelli M, Tosto FA, Zhang X, Melani CJ, et al. Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity. Proc Natl Acad Sci U S A 2024;121:e2413372121.
PMID: 39585996